HonCode

Go Back   HER2 Support Group Forums > Articles of Interest
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 02-20-2009, 09:14 PM   #1
Rich66
Senior Member
 
Rich66's Avatar
 
Join Date: Feb 2008
Location: South East Wisconsin
Posts: 3,431
BC test test will be available later this summer


NATIONAL (NBC) - Researchers have found a new way to isolate specific subsets of breast cancer in a biopsy, a test that just might save a woman unneeded treatments to cure that cancer.
The new test could eliminate the need for chemo or radiation therapy, or any aggressive treatment at all in some patients.
For the first time, it will open a window on a woman's breast cancer that is very specific and targeted for tailor-made therapy.
"I think I was OK with the surgery because I understood that. That is something I was familiar with, but the chemo scared me to death," breast cancer patient Kathy Carlson said.
Carlson is on a new-generation drug for breast cancer.
She's also going through chemotherapy. She's had surgery, and may have to undergo radiation as well.
The treatment is effective, and Carlson's prognosis is good, but oncologists have long been looking for a way to identify the specific personalities of breast cancer so patients like Carlson won't have to go through more than they actually need.
"We found subsets of patients with tumors that are so benign that they just have to have the tumor surgically removed and they'll do fine, even without any additional treatment," said Dr. Philip Bernard, of the Huntsman Cancer Institute.
The new test goes beyond this traditional staining of the sample: Pathologists extract nucleic acid from the cells to identify 50 specific genetic characteristics of the cancer.
Researchers are able to identify over-expressed aggressive genes while and under-expressed genes.
This is a much more complete portrait of the cancer and where it's going, if anywhere.
"Our test showed that we could predict with 97 percent accuracy those patients that will not respond to standard chemotherapy," Bernard said.
In other words, perhaps chemo isn't needed, nor radiation.
Even more so, in some cases the test identifies a subset of women who can be cured without getting any treatment at all, other than the original lumpectomy.
Research took 10 years to complete and involved collaboration with several research groups.
The test will be available later this summer.
Rich66 is offline   Reply With Quote
Old 02-20-2009, 09:15 PM   #2
Rich66
Senior Member
 
Rich66's Avatar
 
Join Date: Feb 2008
Location: South East Wisconsin
Posts: 3,431
Anyone know a working name for the test and whether it can be used on mets tumor slides to predict response to chemo?
Rich66 is offline   Reply With Quote
Old 02-21-2009, 04:47 PM   #3
Jean
Senior Member
 
Join Date: Oct 2005
Location: New Jersey
Posts: 3,154
Rich....this maybe it...

http://www.medicalnewstoday.com/articles/139505.php

This will be a much needed break through !
To finaly have a test to guide for the best treatment !

jean
__________________
Stage 1, Grade 1, 3/30/05
Lumpectomy 4/15/05 - 6MM IDC
Node Neg. (Sentinel node)
ER+ 90% / PR-, Her2+++ by FISH
Ki-67 40%
Arimidex 5/05
Radiation 32 trt, 5/30/05
Oncotype DX test 4/17/06, 31% high risk
TOPO 11 neg. 4/06
Stopped Arimidex 5/06
TCH 5/06, 6 treatments
Herceptin 5/06 - for 1 yr.
9/06 Completed chemo
Started Femara Sept. 2006
Jean is offline   Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On

Forum Jump


All times are GMT -7. The time now is 12:30 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter